Sandoz, the generic arm of Swiss drug maker Novartis, has decided to shut its facility for development of generic drugs in India. The facility, known as Sandoz Development Centre located near......
Sandoz, the generic arm of Swiss drug maker Novartis, recently closed its facility developing active pharmaceutical ingredients (API) near Mumbai, a person close to the development told Business......
The Indian arm of Swiss pharmaceutical major Novartis AG is set to become the newest entrant in the Ayurvedic business. Novartis, already a major player in the Indian over-the-counter (OTC) segment......
Three Indian drug makers - Aurobindo, Glenmark and Sun Pharma - are among the eight generic pharmaceutical producers in race to tap the US market for AstraZeneca's blockbuster cholesterol-reducing......
Amitabh Bachchan is not the brand ambassador for Aviva Life Insurance, yet he's heard repeating 'Jiyo har pal, karo kal par control' -- the tagline of Aviva in the recent promos of the film......